共 50 条
- [22] Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation INTERNATIONAL BRAZ J UROL, 2011, 37 (06): : 706 - 711
- [24] NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (06): : 454 - 458
- [26] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer - Reply JOURNAL OF UROLOGY, 1999, 162 (02): : 501 - 501